Skip to main navigation Skip to search Skip to main content

Docetaxel-loaded composite nanoparticles formed by a temperature-induced phase transition for cancer therapy

  • Soon H. Yuk
  • , Keun S. Oh
  • , Jinah Park
  • , Eun H. Lee
  • , Kwangmeyung Kim
  • , Ick C. Kwon

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Docetaxel-loaded composite nanoparticles were prepared by temperature-induced phase transition of a mixture composed of Pluronic F-68 and liquid Tween 80/soybean oil containing docetaxel. Liquid soybean oil/Tween 80 was used as a solubilizer for docetaxel and Pluronic F-68 to stabilize the liquid soybean oil/Tween 80 containing docetaxel. The phase transition was performed at low temperature to avoid degradation. The docetaxel composite nanoparticles were injected into the tail veins of tumor-bearing mice to evaluate the composite delivery system for the release pattern and the tumor growth. The tumor-targeting capability of composite nanoparticles was verified by noninvasive live animal imaging for the time-dependent excretion profile, the in vivo biodistribution, and the circulation time.

Original languageEnglish
Pages (from-to)441-452
Number of pages12
JournalJournal of Bioactive and Compatible Polymers
Volume27
Issue number5
DOIs
StatePublished - Sep 2012

Bibliographical note

Funding Information:
This study was financially supported by the Korea Research Foundation (20110027932 and 2011K000965) and a grant from the fundamental R&D program for core technology of materials funded by the Ministry of Knowledge Economy, Republic of Korea.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Composite nanoparticles
  • Tween 80/soybean oil
  • antitumor efficacy
  • cancer therapy
  • docetaxel
  • in vivo biodistribution

Fingerprint

Dive into the research topics of 'Docetaxel-loaded composite nanoparticles formed by a temperature-induced phase transition for cancer therapy'. Together they form a unique fingerprint.

Cite this